Chen Biao

[Expert Profile] Chen Biao, Chief Physician, Professor, Doctoral Supervisor, is an authoritative expert in Parkinson's disease and movement disorders in China, working at Xuanwu Hospital, Capital Medical University. He has long focused on the clinical diagnosis, early detection, and translational research of Parkinson's disease, and has made outstanding contributions to promoting standardized diagnosis and whole-course management of Parkinson's disease in China.

[Education & Career] Professor Chen Biao graduated from a renowned medical university, received systematic training at multiple top domestic and international medical institutions, and has profound academic foundations in Parkinson's disease research. After returning to China, he joined Xuanwu Hospital, Capital Medical University, where he led the establishment of the Parkinson's Disease and Movement Disorders Center. He has held academic positions such as leader of the Movement Disorders Group of the Neurology Branch of the Chinese Medical Association, and has presided over major projects including the national "973" Program and key projects of the National Natural Science Foundation of China. He is a representative scholar in China combining basic and clinical research on Parkinson's disease.

[Areas of Expertise] Professor Chen specializes in early diagnosis and differential diagnosis of Parkinson's disease, fine medication adjustment for mid-to-late stage Parkinson's disease, recognition and management of Parkinson-plus syndromes (multiple system atrophy, progressive supranuclear palsy, etc.), and comprehensive treatment of various movement disorders. He has extensive experience in individualized levodopa and anti-Parkinson medication regimens, management of medication adverse effects, and pre-operative assessment and post-operative programming for deep brain stimulation (DBS). He actively advocates a whole-course management model combining exercise rehabilitation, psychological counseling, and multidisciplinary collaboration, significantly improving patients' long-term quality of life.

[Academic Achievements & Industry Contributions] Professor Chen has achieved a series of innovative results in research on early diagnostic biomarkers for Parkinson's disease, leading the establishment of a large-scale Parkinson's disease clinical cohort and biological sample repository, providing important support for early disease warning and precise subtyping. He has led the development of Chinese guidelines and expert consensus for Parkinson's disease diagnosis and treatment, participated in international collaborative research networks related to Parkinson's disease, and actively promoted the application of new technologies such as telemedicine and AI-assisted assessment in whole-course Parkinson's management, bringing China's Parkinson's research and treatment level in line with international advanced standards, and training a large number of movement disorder specialists.

[Clinical Practice & Outstanding Contributions] Professor Chen has long held specialist Parkinson's clinics, cumulatively treating tens of thousands of Parkinson's disease and movement disorder patients, with patients coming from across the country and even overseas. Leading his team, he has established a full-process management system covering pre-consultation assessment, in-consultation treatment, and post-consultation follow-up, optimizing medication regimens for numerous advanced patients and reducing motor complications, enabling many patients who "could not care for themselves" to return to normal life. He has repeatedly organized patient-oriented science popularization lectures and free clinics, and traveled to grassroots hospitals to promote Parkinson's diagnosis and treatment techniques. He is a movement disorders expert whom patients consider "worthy of their trust."

[Honors & Reputation] Professor Chen Biao serves as Director of the National Clinical Research Center for Geriatric Diseases (Xuanwu Hospital), among other academic positions. He has presided over multiple national-level projects including key projects of the National Natural Science Foundation of China and the National Key R&D Program, establishing one of the largest Parkinson's disease clinical and follow-up databases in China. He has led innovative research on early diagnostic biomarkers and neuromodulation therapy for Parkinson's disease, with findings receiving multiple provincial and ministerial science and technology awards. He actively promotes standardized Parkinson's diagnosis and chronic disease whole-course management, and fosters the clinical application of advanced technologies such as deep brain stimulation (DBS). He has trained a large number of Parkinson's disease specialists, and has long been dedicated to public welfare activities for Parkinson's patients. He is deeply trusted by patients and is an authoritative expert in the field of Parkinson's disease in China.